Biopharma Policy in the Spotlight at JPM as Sector Gears Up for Volatile 2024

The Inflation Reduction Act, “march-in rights” to take back patents and M&A were among the issues discussed at a Sunday panel in San Francisco ahead of Monday’s start of the J.P. Morgan conference.

Scroll to Top